Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5253-5265
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5253
Table 1 Patient characteristics
Variable
Chemotherapy (n = 470), n (%)
BSC (n = 652), n (%)
P value
Age
Young (age < 75 yr)375 (79.8)335 (51.4)< 0.001
Elder (age ≥ 75 yr)95 (20.2)317 (48.6)
Sex
Male284 (60.4)363 (55.7)0.112
Female186 (39.6)289 (44.3)
Charlson co-morbidity index score
< 3175 (37.2)343 (52.6)< 0.001
≥ 3295 (62.8)309 (47.4)
Barthel index
≥ 60422 (89.8)436 (66.9)< 0.001
< 6027 (5.7)153 (23.5)
Missing21 (4.5)63 (9.7)
Medication
Aspirin18 (3.8)33 (5.1)0.329
Thienopyridine7 (1.5)24 (3.7)0.027
Warfarin8 (1.7)20 (3.1)0.148
DOACs34 (7.2)29 (4.4)0.045
Other antiplatelet drugs7 (1.5)33 (5.1)0.001
NSAIDs293 (62.3)314 (48.2)< 0.001
Steroids201 (42.8)154 (23.6)< 0.001
Cancer type
Esophageal cancer24 (5.1)83 (12.7)< 0.001
Gastric cancer151 (32.1)113 (17.3)
Pancreatic cancer69 (14.7)106 (16.3)
Colorectal cancer146 (31.1)212 (32.5)
Other cancers80 (17.0)138 (21.2)
Cancer stage
Stage I-III81 (17.2)157 (24.1)0.022
Stage IV or recurrence297 (63.2)379 (58.1)
Missing92 (19.6)116 (17.8)
Obstruction site
Esophageal obstruction38 (8.1)105 (16.1)< 0.001
Gastroduodenal obstruction189 (40.2)233 (35.7)
Lower gastrointestinal obstruction243 (51.7)314 (48.2)
Chemotherapy before the intervention274 (58.3)413 (63.3)0.087
Intervention type
Palliative surgery294 (62.6)283 (43.4)< 0.001
SEMS placement176 (37.4)369 (56.6)